Rituximab Maintenance After Autologous Transplantation

NCT01103388 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Closed early due to slow patient accrual and sponsor's withdrawal of support.

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]